Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13826673 [patent_doc_number] => 20190016821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => STABILIZED PEPTIDE FRAGMENTS FROM PROTOCADHERIN FAT1 AS CANCER BIOMARKERS [patent_app_type] => utility [patent_app_number] => 16/068629 [patent_app_country] => US [patent_app_date] => 2017-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7558 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068629 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/068629
STABILIZED PEPTIDE FRAGMENTS FROM PROTOCADHERIN FAT1 AS CANCER BIOMARKERS Jan 4, 2017 Abandoned
Array ( [id] => 11588514 [patent_doc_number] => 20170112925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/399118 [patent_app_country] => US [patent_app_date] => 2017-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 35418 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399118 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/399118
Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors Jan 4, 2017 Issued
Array ( [id] => 13793395 [patent_doc_number] => 20190010236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => METHODS AND COMPOSITIONS FOR DECTIN-2 STIMULATION AND CANCER IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 16/066154 [patent_app_country] => US [patent_app_date] => 2016-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066154 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/066154
METHODS AND COMPOSITIONS FOR DECTIN-2 STIMULATION AND CANCER IMMUNOTHERAPY Dec 27, 2016 Abandoned
Array ( [id] => 11589739 [patent_doc_number] => 20170114150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'ANTI-BRDU ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/382329 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23863 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382329 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/382329
ANTI-BRDU ANTIBODIES AND METHODS OF USE Dec 15, 2016 Abandoned
Array ( [id] => 13593345 [patent_doc_number] => 20180348221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => Reagents and Methods for Monitoring Breast Cancer Therapy [patent_app_type] => utility [patent_app_number] => 15/781373 [patent_app_country] => US [patent_app_date] => 2016-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9435 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781373 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/781373
Reagents and Methods for Monitoring Breast Cancer Therapy Dec 8, 2016 Abandoned
Array ( [id] => 16941089 [patent_doc_number] => 11053310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-06 [patent_title] => Antibodies for the treatment of cancers [patent_app_type] => utility [patent_app_number] => 15/780334 [patent_app_country] => US [patent_app_date] => 2016-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19456 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780334 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/780334
Antibodies for the treatment of cancers Dec 4, 2016 Issued
Array ( [id] => 13729883 [patent_doc_number] => 20180369409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => TUMOR-SPECIFIC PAYLOAD DELIVERY AND IMMUNE ACTIVATION USING A HUMAN ANTIBODY TARGETING A HIGHLY SPECIFIC TUMOR CELL SURFACE ANTIGEN [patent_app_type] => utility [patent_app_number] => 15/779490 [patent_app_country] => US [patent_app_date] => 2016-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779490 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/779490
Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen Nov 28, 2016 Issued
Array ( [id] => 16985506 [patent_doc_number] => 11072662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-27 [patent_title] => Humanized anti-CLL-1 antibodies [patent_app_type] => utility [patent_app_number] => 15/779025 [patent_app_country] => US [patent_app_date] => 2016-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 22296 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779025 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/779025
Humanized anti-CLL-1 antibodies Nov 21, 2016 Issued
Array ( [id] => 17329204 [patent_doc_number] => 11219645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-11 [patent_title] => Tumor infiltrating lymphocytes for treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/777253 [patent_app_country] => US [patent_app_date] => 2016-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 75 [patent_no_of_words] => 18073 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777253 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/777253
Tumor infiltrating lymphocytes for treatment of cancer Nov 17, 2016 Issued
Array ( [id] => 14005607 [patent_doc_number] => 10221240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-05 [patent_title] => Methods for treatment of gastric cancer [patent_app_type] => utility [patent_app_number] => 15/345618 [patent_app_country] => US [patent_app_date] => 2016-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12029 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15345618 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/345618
Methods for treatment of gastric cancer Nov 7, 2016 Issued
Array ( [id] => 12979870 [patent_doc_number] => 20170342161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => ANTIBODY BINDING TO CARBONIC ANHYDRASE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/344764 [patent_app_country] => US [patent_app_date] => 2016-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15344764 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/344764
Antibody binding to carbonic anhydrase and use thereof Nov 6, 2016 Issued
Array ( [id] => 13533751 [patent_doc_number] => 20180318418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => ANTI-BARF1 MONOCLONAL ANTIBODY [patent_app_type] => utility [patent_app_number] => 15/773296 [patent_app_country] => US [patent_app_date] => 2016-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15773296 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/773296
Anti-BARF1 monoclonal antibody Nov 3, 2016 Issued
Array ( [id] => 16563262 [patent_doc_number] => 10888609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-12 [patent_title] => CD200 inhibitors and methods of use thereof [patent_app_type] => utility [patent_app_number] => 15/773527 [patent_app_country] => US [patent_app_date] => 2016-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 28564 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15773527 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/773527
CD200 inhibitors and methods of use thereof Nov 1, 2016 Issued
Array ( [id] => 12247356 [patent_doc_number] => 09920123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Anti-PD-L1 antibodies, compositions and articles of manufacture' [patent_app_type] => utility [patent_app_number] => 15/335278 [patent_app_country] => US [patent_app_date] => 2016-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 66198 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15335278 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/335278
Anti-PD-L1 antibodies, compositions and articles of manufacture Oct 25, 2016 Issued
Array ( [id] => 11692345 [patent_doc_number] => 20170168061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-15 [patent_title] => 'SPECIFIC BIOMARKER SET FOR NON-INVASIVE DIAGNOSIS OF LIVER CANCER' [patent_app_type] => utility [patent_app_number] => 15/331472 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 5372 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331472 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/331472
Specific biomarker set for non-invasive diagnosis of liver cancer Oct 20, 2016 Issued
Array ( [id] => 11589716 [patent_doc_number] => 20170114127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'VEGF-A-BINDING PROTEINS AND HER2-BINDING PROTEINS WITH ENHANCED STABILITY AGAINST AGGREGATION' [patent_app_type] => utility [patent_app_number] => 15/299861 [patent_app_country] => US [patent_app_date] => 2016-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18105 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299861 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/299861
VEGF-A-BINDING PROTEINS AND HER2-BINDING PROTEINS WITH ENHANCED STABILITY AGAINST AGGREGATION Oct 20, 2016 Abandoned
Array ( [id] => 11949779 [patent_doc_number] => 20170253931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-07 [patent_title] => 'POST-TREATMENT BREAST CANCER PROGNOSIS' [patent_app_type] => utility [patent_app_number] => 15/298128 [patent_app_country] => US [patent_app_date] => 2016-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11570 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15298128 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/298128
Post-treatment breast cancer prognosis Oct 18, 2016 Issued
Array ( [id] => 14185373 [patent_doc_number] => 20190112391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-18 [patent_title] => HEPARANASE-NEUTRALIZING MONOCLONAL ANTIBODIES [patent_app_type] => utility [patent_app_number] => 15/767355 [patent_app_country] => US [patent_app_date] => 2016-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767355 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/767355
Heparanase-neutralizing monoclonal antibodies Oct 12, 2016 Issued
Array ( [id] => 13781017 [patent_doc_number] => 20190004047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => GDF-15 AS A DIAGNOSTIC MARKER FOR MELANOMA [patent_app_type] => utility [patent_app_number] => 15/765187 [patent_app_country] => US [patent_app_date] => 2016-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15765187 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/765187
GDF-15 AS A DIAGNOSTIC MARKER FOR MELANOMA Sep 29, 2016 Abandoned
Array ( [id] => 12565992 [patent_doc_number] => 10017572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Anti-tigit antibodies and methods of use [patent_app_type] => utility [patent_app_number] => 15/274603 [patent_app_country] => US [patent_app_date] => 2016-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 68736 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15274603 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/274603
Anti-tigit antibodies and methods of use Sep 22, 2016 Issued
Menu